ข่าวประชาสัมพันธ์ Press Releases ข่าวย้อนหลัง หัวข้อข่าว บลอก

วันจันทร์ที่ ๑ กันยายน พ.ศ. ๒๕๕๗ ๑๔:๓๑ น.

Food and Healthcare Press Releases

THANYAPURA PIONEERS BESPOKE PERFORMANCE WITH #FIT GENE# Heathcare—๒๕ ส.ค. ๕๗

Thanyapura Phuket's reputation for innovation has been underlined with the launch of Fit Gene - a cutting-edge scientific endeavour that highlights the strengths and weaknesses of someone's genetic makeup to enhance sporting performance. The

Masimo Announces CE Mark and Limited Market Release of rainbow(R) DCI-mini(TM) - First Noninvasive Total Haemoglobin (SpHb(R)) Spot-Check Sensor for Infants and Small Children Heathcare—๒๙ ส.ค. ๕๗

NEUCHATEL, SWITZERLAND--(Marketwired)--Aug 28, 2014

Masimo (NASDAQ: MASI) today announced CE Mark, clearance in Japan, and limited market release of the rainbow(R) DCI-mini(TM), the first noninvasive haemoglobin (SpHb(R)) spot-check sensor for infants and small children (weight 3 to 30 kg). Paired with Masimo's handheld Pronto(R) device, the rainbow(R) DCI-mini sensors are designed to help clinicians quickly and easily spot-check haemoglobin levels, which may facilitate the identification of anaemia -- a condition reflected by low haemoglobin when there are not enough red blood cells carrying oxygen to the tissues. In low-resource countries, an estimated 3.5 billion people are anaemic,1 making it one of the world's most common disorders.

Previously, SpHb spot-check sensors were available only for patients weighing 10 kg or more. Because iron deficient-anaemia during infancy and childhood has been shown to have long-lasting adverse effects on neurodevelopment,2 international health organizations recommend screening infants for anaemia between the ages of 9 to 12 months -- an age that is often below 10 kg -- with additional screening between the ages of 1 and 5 years for patients at risk.3,4

Masimo's rainbow(R) DCI-mini is a versatile sensor that is designed to facilitate proper placement and ease of use for clinicians and patients.

TCELS has shortlisted 10 selected teams from i,Medbot contest Heathcare—๑๘ ส.ค. ๕๗

TCELS has shortlisted 10 selected teams that will go to the “i, MedBot 2014” contest round. We have moved one step closer to getting the best ideas that will receive the total prize money of 300,000 Baht and will be announced on 13 September

Coherus Announces CHS-1420 (Investigational Adalimumab Biosimilar) Meets Primary Endpoint In Heathcare—๑๕ ส.ค. ๕๗

Coherus BioSciences, Inc. ("Coherus") today announced that CHS-1420, its proposed biosimilar of adalimumab (Humira(R)), met the primary endpoint in a pivotal clinical pharmacokinetic (PK) similarity study that compared CHS-1420 to Humira(R) in healthy

A New Beginning: ResMed#s New Air Solutions Connected Care Platform for Treating Sleep-Disordered Heathcare—๑๓ ส.ค. ๕๗

-- Platform Maximizes the Power of Data from Diagnosis to Patient Engagement for the Benefit of All Stakeholders in the Care Continuum ResMed (NYSE: RMD) today announced Air Solutions, a new forward-thinking connected care solution for treating

Herbalife Announces its 2nd CASA Herbalife Program in Thailand In Collaboration with the Baan Heathcare—๑ ส.ค. ๕๗

The Herbalife Family Foundation (HFF), a non-profit corporation dedicated to improving children's lives by helping organizations provide healthy nutrition to vulnerable children, announced the launch of its 2nd CASA Herbalife Program in Thailand, in

Ebola outbreak in West Africa rising number of calls to International Heathcare—๑ ส.ค. ๕๗

International SOS has seen another rise in the number of requests for advice on Ebola in recent weeks. Since 1 March, 2014 the medical and travel security group has received hundreds of requests for advice on the outbreak, which has spread to different

Nichiban Opens Thai Representative Office in Bangkok Heathcare—๓๐ ก.ค. ๕๗

Nichiban Co., Ltd. announced on July 30 that it opened a representative office in Bangkok, Thailand, on July 1. 1. Objective Nichiban opens a representative office in Bangkok primarily for information gathering and market research to promote sales of

Merck Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Heathcare—๒๙ ก.ค. ๕๗

- First patient begins treatment in an international Phase II study investigating the efficacy and safety of MSB0010718C in patients with metastatic Merkel cell carcinoma (mMCC) - mMCC is a rare and aggressive skin cancer lacking effective treatments -

The International Society of Aesthetic Plastic Surgery Releases Statistics on Cosmetic Procedures Heathcare—๒๙ ก.ค. ๕๗

More than 23 million cosmetic surgical and nonsurgical procedures were performed worldwide in 2013, according to statistics released today by the International Society of Aesthetic Plastic Surgery (ISAPS), the leading international society for aesthetic

Fast-Tracking the Global HIV Response - Day 5 at AIDS 2014 Heathcare—๒๕ ก.ค. ๕๗

Sir Bob Geldof told delegates at AIDS 2014, the 20th International AIDS Conference, that the "preposterous reluctance" of governments to fund HIV programs in developing countries is "disgraceful", especially as the journey to the end of the HIV epidemic

Photo Release: Bumrungrad announces Simulation Training Center Heathcare—๒๕ ก.ค. ๕๗

Mr. Dennis Brown (1st from left), Bumrungrad’s Corporate CEO, Dr. Jitra Anuras (2nd from Left), acting Medical Director, together with hospital executives recently announced a unique ‘Simulation Training Center’. Bumrungrad is

Occlutech Wins Invalidation of St Jude Patent Heathcare—๒๔ ก.ค. ๕๗

Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, today announced that it has successfully obtained a ruling by the U.K. Patents Court in the High Court of Justice in London, that invalidates

Asian Health Care Benefits Costs Stabilize, but Larger Hikes Loom, Towers Watson Survey Heathcare—๒๓ ก.ค. ๕๗

The cost of providing employee health care benefits has stabilized around the globe, although a new round of increases may be on the horizon for employers, according to a new survey by Towers Watson (NYSE, NASDAQ: TW), a global professional services

Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Heathcare—๒๓ ก.ค. ๕๗

UL (Underwriters Laboratories), a global safety science leader, has announced that the U.S. Food and Drug Administration (FDA) has recognized two UL battery safety standards as consensus standards for medical devices incorporating lithium or nickel-based

Samitivej-Sano Hospitals Sign MOU for Medical Excellence In Liver and Digestive System Heathcare—๒๑ ก.ค. ๕๗

To enhance medical excellence in liver and digestive system treatment, Samitivej, a leading private hospital in the Southeast Asia region, has partnered with Sano Hospital, a Japanese hospital specialized in endoscopy, to exchange knowledge and

TCELS successfully flew its flag at the 2014 BIO International Convention Heathcare—๒๑ ก.ค. ๕๗

The Thailand Centre of Excellence for Life Sciences (TCELS) successfully flew its flag at the 2014 BIO International Convention established collaborations with US giant firms and government agencies. The 2014 BIO International Convention, held from 23-26

สัมมนาวิชาการทางการแพทย์ Golden Hour in Pediatrics 34 Heathcare—๑๘ ก.ค. ๕๗

สมิติเวช ศรีนครินทร์ ขอเชิญแพทย์ พยาบาล บุคลากรทางการแพทย์ และผู้สนใจทุกท่าน เข้าร่วมงานสัมมนา Golden Hours in Pediatrics 34 “Case-based approach in children with abdominal pain: medical vs. surgical?”

Simbionix#s Innovative Solution for Patient Specific Simulation Receives Further Global Heathcare—๑๗ ก.ค. ๕๗

Medical simulation technology provides an excellent approach to training physicians, nurses and allied health personnel. However, medical simulation development and utilization does not have to stop with training. Simbionix USA Corporation advances the

Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) Heathcare—๑๗ ก.ค. ๕๗

- Company Advances Development as Part of Collaboration with Baxter International's Biopharmaceutical Business Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, a proposed biosimilar of etanercept (Enbrel(R)), in chronic

Newly-Published Study Confirms Stretta to be Valuable GERD Treatment Heathcare—๑๖ ก.ค. ๕๗

A newly published peer-reviewed paper concludes that Stretta therapy is a safe, effective and durable treatment for gastro esophageal reflux disease (GERD). The paper states that Stretta addresses a significant unmet need where patients receive

New Study Evaluates Trending Accuracy and Reliability of Masimo#s Continuous and Noninvasive Heathcare—๑๐ ก.ค. ๕๗

Masimo (NASDAQ: MASI) announced today that a new clinical study published in the Journal of Clinical Monitoring evaluated the relative trending accuracy of Masimo's noninvasive and continuous total hemoglobin (SpHb(R)) in patients with end-stage renal

Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors Heathcare—๑๐ ก.ค. ๕๗

Coherus BioSciences, Inc. ("Coherus"), announced today the appointment of V. Bryan Lawlis, Jr., Ph.D., former President and CEO of Itero Biopharmaceuticals, to its Board of Directors. Logo - http://photos.prnewswire.com/prnh/20120507/SF01448LOGO "It is

TCELS offers latest innovations in health and beauty in Life Science Heathcare—๙ ก.ค. ๕๗

Thailand Center of Excellence for Life Sciences (TCELS), Ministry of Science and Technology, would like to invite you to join “Life Science Garden”, the first event that includes state-of-the-art innovations in health and beauty by Thai